The SNMMI and EANM practice guideline for renal scintigraphy in adults

[1]  M. Donald Blaufox,et al.  Renal background correction and measurement of split renal function: The challenge , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  S. Jang.  Nuclear Medicine in Pediatric Urology , 2015 .

[3]  D. De Palma,et al.  Renal Radionuclide Imaging, an Evergreen Forty Years Old , 2014, Klinische Pädiatrie.

[4]  P. Chaumet‐Riffaud,et al.  Clinical problems in renovascular disease and the role of nuclear medicine. , 2014, Seminars in nuclear medicine.

[5]  G. Manzoni,et al.  Different imaging strategies in febrile urinary tract infection in childhood. What, when, why? , 2013, Pediatric Radiology.

[6]  M. Blaufox,et al.  Guidance document for structured reporting of diuresis renography. , 2012, Seminars in nuclear medicine.

[7]  Rune Sixt,et al.  Guidelines for standard and diuretic renogram in children , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  E. Karabulut,et al.  Differential renal function estimation by dynamic renal scintigraphy: influence of background definition and radiopharmaceutical , 2008, Nuclear medicine communications.

[9]  J. Fettich,et al.  Reproducibility of 99mTc-mercaptoacetyltriglycine renography: population comparison , 2008, Nuclear medicine communications.

[10]  Russell D Folks,et al.  99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume. , 2006, AJR. American journal of roentgenology.

[11]  John O. Prior,et al.  Radionuclide investigations of the urinary tract in the era of multimodality imaging. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  J. Fleming.  A technique for analysis of geometric mean renography , 2006, Nuclear medicine communications.

[13]  M. Issa,et al.  Comparison of camera-based 99mTc-MAG3 and 24-hour creatinine clearances for evaluation of kidney function. , 2006, AJR. American journal of roentgenology.

[14]  A. Taylor.  ACE inhibition renography in the evaluation of suspected renovascular hypertension , 2006 .

[15]  D. Volterrani,et al.  Captopril radionuclide test in renovascular hypertension: a European multicentre study , 1993, European Journal of Nuclear Medicine.

[16]  W. N. Tauxe,et al.  New formulas for the calculation of effective renal plasma flow , 2004, European Journal of Nuclear Medicine.

[17]  K. Itoh.  Comparison of methods for determination of glomerular filtration rate: Tc-99m-DTPA renography, predicted creatinine clearance method and plasma sample method , 2003, Annals of nuclear medicine.

[18]  R. Chisin,et al.  Tc-99m Mercaptoacetyltriglycine Clearance: Comparison of Camera-Assisted Methods , 2001, Clinical nuclear medicine.

[19]  K. Hahn,et al.  Guidelines for 99mTc-DMSA scintigraphy in children. , 2001, European journal of nuclear medicine.

[20]  K. Hahn,et al.  Guidelines for glomerular filtration rate determination in children. , 2001, European journal of nuclear medicine.

[21]  M. Mathai,et al.  Determination of glomerular filtration rate using a dual-detector gamma camera and the geometric mean of renal activity: correlation with the Tc-99m DTPA plasma clearance method. , 2000, Clinical nuclear medicine.

[22]  C. Russell,et al.  Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  G. F. Gates,et al.  Consensus report on quality control of quantitative measurements of renal function obtained from the renogram: International Consensus Committee from the Scientific Committee of Radionuclides in Nephrourology. , 1999, Seminars in nuclear medicine.

[24]  A. Taylor,et al.  Report of the Radionuclides in Nephrourology Committee for evaluation of transplanted kidney (review of techniques). , 1999, Seminars in nuclear medicine.

[25]  M. Lythgoe,et al.  Assessment of various parameters in the estimation of differential renal function using technetium-99m mercaptoacetyltriglycine , 1999, European Journal of Nuclear Medicine.

[26]  J. Valentin,et al.  Radiation dose to patients from radiopharmaceuticals: (Addendum 2 to ICRP Publication 53) ICRP Publication 80 Approved by the Commission in September 1997 , 1998, Annals of the ICRP.

[27]  Göran Granerus,et al.  Procedure guideline for diagnosis of renovascular hypertension , 1998 .

[28]  M. Blaufox,et al.  Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  B. Kemp,et al.  Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance. , 1997, Radiology.

[30]  M. Aurell,et al.  Consensus on diuresis renography for investigating the dilated upper urinary tract. Radionuclides in Nephrourology Group. Consensus Committee on Diuresis Renography. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  A. Taylor,et al.  Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  M D Blaufox,et al.  Report of the Radionuclides in Nephrourology Committee on renal clearance. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  Ernest V. Garcia,et al.  Measuring technetium-99m-MAG3 clearance with an improved camera-based method. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  C. Russell,et al.  Quantitation of renal parenchymal retention of technetium-99m-MAG3 in renal transplants. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  P. Cosgriff,et al.  Towards standardization in gamma camera renography. , 1992, Nuclear medicine communications.

[36]  P H O'Reilly,et al.  Diuresis renography. Recent advances and recommended protocols. , 1992, British journal of urology.

[37]  D. Eshima,et al.  Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  M. Blaufox,et al.  The Einstein/Cornell collaborative protocol to assess efficacy and methodology in captopril scintirenography. Early results in patients with essential hypertension. Report of the Einstein/Cornell Collaborative Hypertension Group. , 1991, American journal of hypertension.

[39]  M. Blaufox.  Procedures of choice in renal nuclear medicine. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  A. Dobbeleir,et al.  Effect of background correction on separate technetium-99m-DTPA renal clearance. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  R. Müller-Suúr,et al.  Glomerular filtration and tubular secretion of MAG-3 in the rat kidney. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  G. Sfakianakis,et al.  Nuclear medicine in pediatric urology and nephrology. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[43]  B. Bubeck.  The tubular extraction rate (TER) of ^ Tc-MAG3: A new quantitative parameter of renal function , 1987 .

[44]  D. Eshima,et al.  Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  D. Farrar,et al.  Diuresis renography in equivocal urinary tract obstruction. , 1978, British journal of urology.

[46]  Gates Gf,et al.  Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). , 1982, AJR. American journal of roentgenology.

[47]  G. F. Gates,et al.  Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). , 1982, AJR. American journal of roentgenology.

[48]  M. Blaufox,et al.  Tc-99m DMSA renal uptake: influence of biochemical and physiologic factors. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  C. Brown,et al.  Dynamic renal transplant imaging with Tc-99m DTPA (Sn) supplemented by a transplant perfusion index in the management of renal transplants. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[50]  P. Kirchner,et al.  Clinical application of the kidney to aortic blood flow index (K/A ratio). , 1978, Contributions to nephrology.

[51]  S. Treves,et al.  Renal localization of 99mTc-stannous glucophetonate and 99mTc-stannous dimercaptosuccinate in the rat by frozen section autoradiography. The efficiency and resolution of technetium-99m. , 1977, Radiation research.

[52]  J. Schlegel,et al.  Individual renal plasma flow determination in 2 minutes. , 1976, The Journal of urology.

[53]  T. H. Lin,et al.  A 99mTc-chelate substitute for organoradiomercurial renal agents. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[54]  W. Mckay,et al.  99Tcm gluconate complexes for renal scintigraphy. , 1973, The British journal of radiology.

[55]  T. Barratt,et al.  Estimation of Glomerular Filtration Rate from Plasma Clearance of 51-Chromium Edetic Acid , 1972, Archives of disease in childhood.

[56]  H. Atkins,et al.  Technetium-99m DTPA: a new radiopharmaceutical for brain and kidney scanning. , 1970, Radiology.

[57]  J. Radó,et al.  Radioisotope Renography During Furosemide (Lasix) Diuresis , 1968, Nuklearmedizin.

[58]  G. Thorburn,et al.  Chromium-51 Ethylenediaminetetraacetate for Estimation of Glomerular Filtration Rate , 1966, Science.

[59]  R. Nordyke,et al.  Preparation and Use of I131 Labeled Sodium Iodohippurate in Kidney Function Tests , 1960 .